Gilead Sciences Gets FDA Approval For Covid-19 Treatment RemdesivirInvestors Business Daily • 10/22/20
U.S. Food and Drug Administration Approves Gilead's Antiviral Veklury® (remdesivir) for Treatment of COVID-19Business Wire • 10/22/20
Gilead Announces New Data on Biktarvy® for the Treatment of HIV in Black AmericansBusiness Wire • 10/21/20
Gilead Coronavirus Drug Treated President — But Is GILD Stock A Buy?Investors Business Daily • 10/20/20
Does This Metric Tell Investors All They Need to Know About Gilead Sciences?The Motley Fool • 10/18/20
Study finds remdesivir, hydroxychloroquine have 'little' impact on mortality in COVID-19 patientsMarket Watch • 10/16/20